Pycnogenol® Normalizes Cardio Risks During Perimenopause
02-Apr-2017 | PDF file - by Horphag Research (USA) Inc.Download PDF Now!
A new study builds upon previous research showing the benefits of Pycnogenol® for alleviating perimenopause symptoms and is the first study to show effects on cardiovascular risk markers, homocysteine and CRP levels.
Daily Pycnogenol® supplementation reduced and normalized elevated cardiovascular risk factors often related to perimenopause: cholesterol, triglycerides, blood pressure and blood glucose. Participants also reported significant relief of hot flashes, reduction of night sweats and mood improvement.